Allergy and Immunology
2025 DATA
Leaders
PIs
|
Research
LocationDepartment of Immunology Fundación Jiménez Díaz University Hospital. Avda. Reyes Católicos, 2. 28040 Madrid (Spain). Allergy, Immunology and Proteomics Laboratories 4th Floor, Research Building IIS-FJD Fundación Jiménez Díaz University Hospital. Avda. Reyes Católicos, 2. 28040 Madrid (Spain). KeywordsAllergy, Asthma, Anaphylaxis, Immunology, Cardiovascular Diseases, Diagnostics, Disease Mechanisms, Metabolomics, Proteomics, Renal Diseases, Therapy, Extracellular Vesicles |
Gender perspective

Summary of activities
The group’s clinical and research activities focus on the study of diseases with an immunological basis, primarily allergic and cardiovascular disorders, as well as on the identification of diagnostic and prognostic biomarkers through omics-based approaches, particularly in the cardiorenal field. In both acute inflammatory conditions, such as anaphylaxis, and chronic inflammatory diseases, including asthma and vascular wall remodelling, the group investigates the immunopathogenic mechanisms and signalling pathways underlying disease development and progression. In parallel, efforts are directed towards the development of innovative tools aimed at improving disease diagnosis, prognosis and treatment.
Contributions to society
Over the last decade, the group has contributed to society with the publication of more than 600 original articles and review papers in high-impact scientific journals, the development of 20 clinical guidelines and management protocols, and the filing of two patents. The group maintains strong engagement with society through close collaboration with patient associations and by carrying out dissemination and outreach activities in school settings. In addition, members of the group have carried out educational videos and actively participated in media outreach initiatives, sharing their expertise and contributing to public awareness and improved understanding of these diseases.
Collaborations
The group is an active member of several Spanish and European scientific societies in the fields of Allergy, Immunology, Cardiovascular and Kidney disease, and is represented on the Executive Committee of the European Academy of Allergy and Clinical Immunology (EAACI). At the national level, the Group participates in CIBERES and RICORS2040 and maintains numerous collaborative links with leading researchers through both intra and extramural networks and initiatives, including CIBERES, ARADyAL, REI, GEIVEX, PROTEORED and SESMET.
At the international level, the group has established numerous long-standing collaborations with leading research teams and institutions worldwide. In addition, all group leaders serve on the editorial boards of prestigious international journals and actively contribute as editors to leading publications in their respective fields.
PhD Theses

List of publications
Occupational Asthma Due to Hair Dyes Containing Para-Amino Compounds.
Doyen V, Walusiak-Skorupa J, Wiszniewska M, Vandenplas O, Suuronen K, Sastre J, Svanes C, Folletti I, Munoz X, de Blay F, Rifflart C, Seed M, Suojalehto H.
Am J Ind Med. 2026 Jan.69(1):42-48.
PMID: 41255046
FI: 3,1
http://dx.doi.org/10.1002/ajim.70037
CCL18: a potential immunosuppressive biomarker for prognosis in ABC diffuse large B-cell lymphoma.
Rodríguez M, Rojas-Vega F, Díaz-Alejo JF, Mahillo-Fernández I, Serrano C, López A, Morales-Ruiz T, Roldan-Arjona T, Sánchez-García J, Río-Machín A, Morillo D, Pérez MA, Córdoba R, Llamas-Sillero P, Rodríguez-Pinilla SM, Serrano-López J.
Front Immunol. 2025.16:1693730.
PMID: 41472741
FI: 5,9
http://dx.doi.org/10.3389/fimmu.2025.1693730
Mixed Nut Challenge Test (MixNut) as an Efficient Procedure in the Management of Lipid Transfer Protein Allergy.
Betancor D, Haroun E, De Las Heras Gozalo M, Pastor-Vargas C, Cuesta-Herranz J.
Nutrients. 2025 Dec 06.17(24).
PMID: 41470767
FI: 5
http://dx.doi.org/10.3390/nu17243822
Differential DNA methylation in infants with IgE- and non-IgE-mediated cow's milk allergy and its association with acquired tolerance.
López-Gómez R, Gil-Martínez M, Ladrón-Guevara A, Rodrigo-Muñoz JM, Lorente-Sorolla C, Rodríguez-González D, García de Castro Z, Guillén-Sánchez G, Serrano-Santiago A, Mirasierra-Pérez R, Cañas JA, Del Río Camacho G, Del Pozo V.
Front Immunol. 2025.16:1571987.
PMID: 41394805
FI: 5,9
http://dx.doi.org/10.3389/fimmu.2025.1571987
Uncovering mirnomes of patients with interstitial lung diseases and an underlying autoimmune process.
Sánchez-Pernaute O, Benítez Y, Vadillo Font C, Nieto MA, Cebrián L, López-Muñiz B, Romero-Bueno FI, Godoy H, Laporta R, Del Pozo Abeijón MV, Abásolo Alcázar L, Mínguez P, Rodríguez Nieto MJ.
Respir Res. 2025 Dec 05.
PMID: 41350880
FI: 5
http://dx.doi.org/10.1186/s12931-025-03392-6
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments.
Sousa-Pinto B, Bousquet J, Vieira RJ, Schünemann HJ, Zuberbier T, Bognanni A, Togias A, Samolinski B, Valiulis A, Williams S, Bedbrook A, Czarlewski W, Torres MJ, Shamji MH, Morais-Almeida M, Canonica GW, Vecillas LL, Dykewicz MS, Jacomelli C, Klimek L, Leemann L, Lourenço O, Palamarchuk Y, Papadopoulos NG, Pereira AM, Savouré M, Toppila-Salmi SK, Ventura MT, Yepes-Nuñez JJ, Cruz AA, Ciprandi G, Gemicioglu B, Giovannini M, Gradauskiene B, Jartti T, Jeseňák M, Kuna P, Kvedariene V, Larenas-Linnemann DE, Latiff AH, Mohammad Y, Ohta K, Mahesh PA, Pali-Schöll I, Pfaar O, Regateiro FS, Roche N, Taborda-Barata L, Ulrik CS, Rostan MV, Viegi G, Zhang L, Haahtela T, Cherrez-Ojeda I, Carlos Ivancevich J, Khaltaev N, Yorgancioglu A, Abdullah B, Al-Ahmad M, Al-Nesf MA, Amaral R, Asllani J, Bergmann KC, Bernstein JA, Blaiss MS, Braido F, Camargos P, Carreiro-Martins P, Casale T, Cecchi L, Fiocchi A, Giuliano AFM, Christoff G, Cirule I, de Sousa JC, Costa EM, Del Giacco S, Devillier P, Dokic D, Hossny E, Iinuma T, Irani C, Ispayeva Z, Julge K, Kaidashev I, Bennoor KS, Kraxner H, Kull I, Kulus M, Kupczyk M, Kurchenko A, La Grutta S, Miculinic N, Tuyet LLT, Makris M, Milenkovic B, Lee SM, Montefort S, Moreira A, Mullol J, Nadif R, Nakonechna A, Neffen HE, Niedoszytko M, Nyembue D, O'Hehir RE, Ogulur I, Okamoto Y, Olze H, Palomares O, Panzner P, Patella V, Pawankar R, Pitsios C, Popov TA, Puggioni F, Quirce S, Ramonaité A, Recto M, Repka-Ramirez MS, Roberts G, Robles-Velasco K, Rottem M, Salapatas M, Sastre J, Scichilone N, Sisul JC, Solé D, Soto-Martinez ME, Sova M, Tantilipikorn P, Todo-Bom A, Tsaryk V, Tsiligianni I, Urrutia-Pereira M, Valovirta E, Vasankari T, Wallace D, Wang Y, Worm M, Yusuf OM, Zidarn M, Gil-Mata S, Marques-Cruz M, Mahboub B, Ansotegui IJ, Romano A, Aberer W, Artesani MC, Azzolini E, Barreto B, Bartra J, Becker S, Beghe B, Boner A, Borowiack E, Bouchard J, Bourgoin-Heck M, Brussino L, Buhl R, Castillo-Vizuete JA, Charpin D, Chavannes NH, Chełmińska M, Cheng L, Chkhartishvili E, Cho SH, Chong-Neto HJ, Choudhury D, Chu DK, Cingi C, Compalati E, Costa RA, Cunha OM, Cvetkovski B, Cardona-Dahl V, D'Amato G, Davies J, Di Bona D, Gonzalez Diaz SN, Dimou MV, Doulaptsi M, Ferreira-da-Silva R, Gawlik R, Calvo-Gil M, Goksel O, Gómez MR, Gotua M, Grigoreas C, Grisle I, Guzman MA, Tan RH, Hyland M, Ierodiakonou D, Karavelia A, Keith P, Kisiel M, Kosak TS, Kosnik M, Koyuncu IV, Kritikos V, Litynska J, Lombardi C, Louis G, Martini M, Meço C, Mesonjesi E, Mihaltan F, Moniuszko M, Naclerio RN, Nadeau KC, Neisinger S, Ollert M, Ordak M, Paoletti G, Park HS, Parmelli E, Perdomo-Flores EA, Pérez JMF, Pham-Thi N, Prokopakis E, Ribeiro-Vaz I, Rolla G, Romantowski J, Rombaux P, Rouadi PW, Rukhadze M, Ryan D, Sadowska E, Sakurai D, Salameh L, Sarquis FS, Serrano E, Da Silva J, Soyka M, Specjalski K, Tomic-Spiric V, Stevanovic K, Subramaniam A, Teixeira MDC, Thomander T, Vachova M, van Hage M, Vichyanond P, Wagenmann M, Ko FWS, Werminghaus P, Xepapadaki PV, Xiang YK, Yang Q, Yeverino DR, Zuberbier J, Fonseca JA.
Allergy. 2025 Dec 01.
PMID: 41324154
FI: 12
http://dx.doi.org/10.1111/all.70131
Impact of Cooking Methods on Egg Allergenicity: Clinical Insights and Protein Profiling.
Rodríguez-Trabado A, Pineda F, Tsopanas A, Martinez MJ, Bastidas JA, Vega A.
J Investig Allergol Clin Immunol. 2025 Dec 16.35(6):472-474.
PMID: 41262064
FI: 6,7
http://dx.doi.org/10.18176/jiaci.1107
Why Physicians Choose Allergology? Insights from a CAJMIR Cross-Sectional Study.
Moya B, Betancor D, Sobrino García M, Álvarez-Sala P, García Gutiérrez I, Fernández de Alba Porcel I, Young Allergologists and Medical Residents Committee (CAJMIR) of the Spanish Society of Allergology and Clinical Immunology (SEAIC).
J Investig Allergol Clin Immunol. 2025 Dec 16.35(6):465-467.
PMID: 41262058
FI: 6,7
http://dx.doi.org/10.18176/jiaci.1109
T, B, and NK cells versus the primary immunodeficiency orientation tube for diagnostic screening of IEIs.
Perez-Andres M, van der Burg M, Kalina T, Bonroy C, Silva SL, Lopez-Granados E, Arriba-Méndez S, Serrano C, Torres RC, Paiva A, Gonzalez-Granado LI, Sousa AE, Hofmans M, van Dongen JJM, Orfao A, EuroFlow Consortium.
J Allergy Clin Immunol. 2025 Dec.156(6):1772-1775.
PMID: 41105067
FI: 11,2
http://dx.doi.org/10.1016/j.jaci.2025.09.021
High Ferritin Predicts Mortality in Patients With Interstitial Pneumonia and an Underlying Autoimmune Disease.
Rodríguez-Nieto MJ, Romero-Bueno F, Abásolo L, Vegas Sánchez MC, López-Botet Zulueta B, Sánchez-Pernaute O, NEREA Autoimmune ILD Study Group.
Open Respir Arch. 2025.7(3):100455.
PMID: 41054703
FI: 0
http://dx.doi.org/10.1016/j.opresp.2025.100455
Excessive glycosylation drives thoracic aortic aneurysm formation through integrated stress response.
Rochano-Ortiz A, San Sebastián-Jaraba I, Zamora C, Simó C, García-Cañas V, Martínez-Albaladejo S, Fernández-Gómez MJ, Marcos-Ríos D, Martínez-Núñez P, Martín-Lorenzo M, Velho TR, Ruíz-Rodríguez MJ, Leal-Zafra A, Gabandé-Rodríguez E, Martínez-Martínez S, Guala A, Lorenzo Ó, Blanco-Colio LM, Martín-Ventura JL, Álvarez-Llamas G, Aldamiz-Echevarría G, Teixidó-Tura G, Forteza A, Nistal JF, Redondo JM, Méndez-Barbero N, Mittelbrunn M, Oller J.
Eur Heart J. 2025 Dec 01.46(45):4988-5005.
PMID: 40720766
FI: 35,7
http://dx.doi.org/10.1093/eurheartj/ehaf556
Stability of Asthma Biomarkers Over a Two-year Period Using Three Distinct Classifications in the MEGA Cohort.
Betancor D, Rial MJ, Olaguibel JM, Del Pozo V, Alvarez Puebla MJ, Arismendi E, Barroso B, Bobolea I, Cárdaba B, Cañas JA, Domínguez-Ortega J, Crespo-Leshman A, Cruz MJ, Garcia de la Fuente A, González-Barcala FJ, Luna-Porta JA, Martínez-Rivera C, Mullol J, Muñoz X, Plaza V, Quirce S, Soto-Retes L, Valverde-Monge M, Sastre J.
Arch Bronconeumol. 2025 Dec.61(12):794-796.
PMID: 40707281
FI: 9,2
http://dx.doi.org/10.1016/j.arbres.2025.06.016
Editorial: Women in science: allergy research.
Carreras-Badosa G, Esteban V, Hernandez-Trujillo V, Toskala E, Mukherjee M, Al Heialy S, Fieten K.
Front Allergy. 2025.6:1601916.
PMID: 40342923
FI: 3,1
http://dx.doi.org/10.3389/falgy.2025.1601916
Changes in serum periostin levels in uncontrolled asthma in children (DADO phase 2 study).
Mena AH, Garijo MAG, Abejón VDP, Vidigal FFR.
Allergol Immunopathol (Madr). 2025.53(1):1-7.
PMID: 39786869
FI: 2,1
http://dx.doi.org/10.15586/aei.v53i1.1134
Mesenchymal stem cells-like as a prognostic biomarker in patients diagnosed with acute myeloid leukemia.
Castaño-Bonilla T, Láinez-González D, Serrano J, Atance M, Mata R, Serrano C, Olivera R, Salgado R, Capellán R, Castellanos G, Blas C, Pardo L, Solán L, Rosado B, Yuste M, Beltran P, Lázaro A, Mahillo I, Oliva E, Llamas P, Alonso-Domínguez JM.
Sci Rep. 2025 Nov 28.15(1):42680.
PMID: 41315789
FI: 3,9
http://dx.doi.org/10.1038/s41598-025-26852-x
Chicory-Induced Anaphylaxis: Characterization of Peroxidase as a Novel Allergen.
Otal-Buesa M, Baptista-Serna L, Nuñez-Borque E, Fernández-Bravo S, Esteban V, Sastre J.
J Investig Allergol Clin Immunol. 2025 Nov 20:0.
PMID: 41277644
FI: 6,7
http://dx.doi.org/10.18176/jiaci.1113
Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024-2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms.
Bousquet J, Sousa-Pinto B, Vieira RJ, Schünemann HJ, Zuberbier T, Bognanni A, Togias A, Samolinski B, Valiulis A, Williams S, Bedbrook A, Czarlewski W, Torres MJ, Shamji MH, Morais-Almeida M, Canonica GW, Vecillas LL, Dykewicz MS, Jacomelli C, Klimek L, Leemann L, Lourenço O, Palamarchuk Y, Papadopoulos NG, Pereira AM, Savouré M, Toppila-Salmi SK, Ventura MT, Yepes-Nuñez JJ, Cruz AA, Ciprandi G, Gemicioglu B, Giovannini M, Gradauskiene B, Jartti T, Jeseňák M, Kuna P, Kvedariene V, Larenas-Linnemann DE, Latiff AHA, Mohammad Y, Ohta K, Mahesh PA, Pali-Schöll I, Pfaar O, Regateiro FS, Roche N, Sofiev M, Taborda-Barata L, Ulrik CS, Rostan MV, Viegi G, Zhang L, Antó JM, Haahtela T, Cherrez-Ojeda I, Ivancevich JC, Khaltaev N, Yorgancioglu A, Abdullah B, Al-Ahmad M, Al-Nesf MA, Amaral R, Asllani J, Bergmann KC, Bernstein JA, Blaiss MS, Braido F, Camargos P, Carreiro-Martins P, Casale T, Cecchi L, Fiocchi AG, Giuliano AFM, Christoff G, Cirule I, Correia-de-Sousa J, Costa EM, Del Giacco S, Devillier P, Dokic D, Hossny E, Iinuma T, Irani C, Ispayeva Z, Julge K, Kaidashev I, Bennoor KS, Kraxner H, Kull I, Kulus M, Kupczyk M, Kurchenko A, La Grutta S, Miculinic N, Tuyet LLT, Makris M, Milenkovic B, Lee SM, Montefort S, Moreira A, Mullol J, Nadif R, Nakonechna A, Neffen HE, Niedoszytko M, Nyembue D, O'Hehir R, Ogulur I, Okamoto Y, Olze H, Palomares O, Panzner P, Patella V, Pawankar R, Pitsios C, Popov TA, Puggioni F, Quirce S, Ramonaité A, Recto M, Repka-Ramirez MS, Roberts G, Robles-Velasco K, Rottem M, Salapatas M, Sastre J, Scichilone N, Sisul JC, Solé D, Soto-Martinez ME, Sova M, Tantilipikorn P, Todo-Bom A, Tsaryk V, Tsiligianni I, Urrutia-Pereira M, Valovirta E, Van Ganse E, Vasankari T, Wallace D, Wang Y, Worm M, Yusuf OM, Zidarn M, Gil-Mata S, Marques-Cruz M, Mahboub B, Ansotegui IJ, Romano A, Artesani MC, Barreto B, Becker S, Beghe B, Bouchard J, Bourgoin-Heck M, Brussino L, Buhl R, Calvo-Gil M, Dahl VC, Vizuete JAC, Charpin D, Chavannes NH, Chełmińska M, Cheng L, Chkhartishvili E, Chong-Neto HJ, Choudhury D, Chu D, Cingi C, Compalati E, Cvetkovski B, Da Silva J, D'Amato G, Davies J, Di Bona D, Dimou MV, Teixeira MDC, Doulaptsi M, Pérez JMF, Gawlik R, Goksel O, Gómez MR, Gonzalez Diaz SN, Gotua M, Grigoreas C, Grisle I, Guzman MA, Tan RH, Hyland M, Ierodiakonou D, Karavelia A, Kisiel M, Kosnik M, Kritikos V, Lombardi C, Martini M, Meço C, Mesonjesi E, Mihaltan F, Moniuszko M, Naclerio R, Neisinger S, Ordak M, Paoletti G, Perdomo-Flores EA, Pham-Thi N, Prokopakis E, Yeverino DR, Rolla G, Romantowski J, Rouadi PW, Rukhadze M, Sakurai D, Salameh L, Sarquis FS, Kosak TS, Soyka M, Sozinova O, Specjalski K, Tomic-Spiric V, Vachova M, van Hage M, Koyuncu IV, Vichyanond P, Wagenmann M, Ko FWS, Werminghaus P, Xepapadaki VP, Xiang YK, Fonseca JA.
Allergy. 2025 Nov 21.
PMID: 41268627
FI: 12
http://dx.doi.org/10.1111/all.70100
Assessment of the Effectiveness of Allergic Rhinitis Medications Using a Target Trial Emulation Approach Based on Mobile Health Data.
Lourenço-Silva N, Sousa-Pinto B, Bognanni A, Martini M, Ordak M, Paoletti G, Gil-Mata S, Amaral R, Bedbrook A, Bonadonna P, Brussino L, Canonica GW, Coutinho-Almeida J, Cruz AA, Czarlewski W, Dykewicz M, Giovannini M, Gemicioglu B, Ivancevich JC, Klimek L, Kvedariene V, Larenas-Linnemann DE, Marques-Cruz M, Moreira A, Niedoszytko M, Pereira AM, Papadopoulos NG, Pham-Thi N, Regateiro FS, Toppila-Salmi SK, Samolinski B, Sastre J, Taborda-Barata L, Thomander T, Koyuncu IV, Valiulis A, Vecillas LL, Ventura MT, Walusiak-Skorupa J, Xiang YK, Pfaar O, Fonseca JA, Zuberbier T, Schünemann HJ, di Bona D, Bousquet J, Vieira RJ.
Clin Exp Allergy. 2025 Nov 09.
PMID: 41207877
FI: 6,4
http://dx.doi.org/10.1111/cea.70173
Quality Assessment of Therapeutic Drug Monitoring Assays of Therapeutic Antibodies Across Europe: An Update.
Bluett J, Rumano M, Martínez Becerra MJ, Loeff F, Itik M, Ternant D, Desvignes C, Mulleman D, Skrede S.
Basic Clin Pharmacol Toxicol. 2025 Nov.137(5):e70129.
PMID: 41048129
FI: 3,3
http://dx.doi.org/10.1111/bcpt.70129
Immunologic biomarkers of noninfectious complications and overall survival in common variable immunodeficiency.
Torres-Valle A, Neirinck J, Silva SL, de Arriba S, Serrano C, Cordón L, Arenas-Caro PP, Subirá D, Mercado MR, González Granado LI, Martins C, Kalina T, Balastegui-Martín H, Cabanero-Navalon MD, Marcos M, Ines S, Contreras T, Prieto C, Guerrero L, García Cañadas MC, Cordeiro AI, Albarran B, Gómez NG, Hurtado G, Barez A, Madruga I, García-Sancho AM, Bastida JM, Davila I, Aragon L, Requejo Olaizola PM, Hofmans M, De Vriendt C, Blanco E, Jara-Acevedo M, Kerre T, Sempere A, Haerynck F, Prada Á, Sousa AE, Bonroy C, van Dongen JJM, Pérez-Andrés M, Orfao A, EuroFlow Consortium.
J Allergy Clin Immunol. 2025 Oct 30.
PMID: 41176068
FI: 11,2
http://dx.doi.org/10.1016/j.jaci.2025.10.020
Comparison Between a Rush and a Conventional Oral Immunotherapy Protocol to Treat Cow's Milk and Hen's Egg Allergy. CompITO Study Methodology.
Eusebio-Cartagena I, Jiménez-Saiz R, Esteban V, Nuñez-Borque E, Ruiz-Sánchez A, Escudero C, Sánchez-García S, Trujillo J, Dunn-Galvin A, Ibáñez-Sandin MDP, Rodríguez Del Río P.
Clin Exp Allergy. 2025 Oct 30.
PMID: 41168926
FI: 6,4
http://dx.doi.org/10.1111/cea.70168
Impact of Physical Exercise on Adult Asthma Control: A Randomized Clinical Trial.
Micozzi S, Gajate Fernández P, Sánchez López P, Laiseca García J, Pérez Rivas FJ.
Healthcare (Basel). 2025 Oct 20.13(20).
PMID: 41154312
FI: 2,7
http://dx.doi.org/10.3390/healthcare13202634
Role of Inflammasome in IgE-Mediated Anaphylaxis.
Fernandez-Bravo S, Fernandez-Santamaria R.
Allergy. 2025 Oct 25.
PMID: 41137486
FI: 12
http://dx.doi.org/10.1111/all.70123
Independent preoperative predictors of day-of-surgery red cell transfusion in major orthopedic surgery: a six-year retrospective cohort of 7072 patients.
Ortiz-Gómez JR, Ortiz-Domínguez A, Fornet-Ruíz I, Palacio-Abizanda FJ.
Braz J Anesthesiol. 2025 Oct 11.76(2):844685.
PMID: 41083103
FI: 1,9
http://dx.doi.org/10.1016/j.bjane.2025.844685
Serum KL-6 as a biomarker to predict progression at one year in interstitial lung disease.
Bonella F, Vegas Sanchez MC, d'Alessandro M, Millan-Billi P, Santos RF, Schröder N, Bastos HN, Molina-Molina M, Pernaute OS, Villegas DC, Bargagli E.
Sci Rep. 2025 Oct 09.15(1):35243.
PMID: 41068354
FI: 3,9
http://dx.doi.org/10.1038/s41598-025-22483-4
Evaluating the Influence of CHI3L1 and PI3 Methylation in Allergic and Nonallergic Asthma.
Baos S, Cremades-Jimeno L, de Pedro MÁ, López-Ramos M, Fernández-Santamaría R, Rosales-Ariza C, Quiralte J, Florido F, González-Mangado N, Rodríguez-Nieto MJ, Peces-Barba G, Sastre J, Cárdaba B.
Biomolecules. 2025 Sep 25.15(10).
PMID: 41154593
FI: 4,8
http://dx.doi.org/10.3390/biom15101363
Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK-air and EAACI Methodological Committee Report.
Sousa-Pinto B, Vieira RJ, Bognanni A, Martini M, Ordak M, Paoletti G, Gil-Mata S, Amaral R, Bedbrook A, Bonadonna P, Brussino L, Canonica GW, Coutinho-Almeida J, Cruz ÁA, Czarlewski W, Dykewicz M, Giovannini M, Gemicioglu B, Ivancevich JC, Klimek L, Kvedariene V, Larenas-Linnemann DE, Marques-Cruz M, Moreira A, Niedoszytko M, Pereira AM, Papadopoulos NG, Pham-Thi N, Regateiro FS, Toppila-Salmi SK, Samolinski B, Sastre J, Taborda-Barata L, Thomander T, Koyuncu IV, Valiulis A, Vecillas LL, Ventura MT, Walusiak-Skorupa J, Xiang YK, Pfaar O, Fonseca JA, Zuberbier T, Schünemann HJ, di Bona D, Bousquet J.
Allergy. 2025 Sep 26.
PMID: 41001805
FI: 12
http://dx.doi.org/10.1111/all.70055
Drug hypersensitivity reactions in children in clinical practice: A WAO Statement.
Steering Committee Authors, Berges-Gimeno MP, Alvarez-Cuesta E, Atanaskovic-Markovic M, Attanassi M, Caffareli C, Caubet JC, du Toit G, Guzman-Melendez A, Kuyucu S, Madrigal-Burgaleta R, Mayorga L, Powell E, Ramien M, Gomes ER, Mori F, White AA, Ansotegui IJ, Review Panel Authors, Vivolo Aun M, Barbaud A, Bavbek S, Bernal-Rubio L, Brockow K, Bustamante L, Chang YS, Chiaverini Ensina LF, Cuesta-Herranz J, Fernandes BN, Garvey LH, Giavina-Bianchi P, Kidon MI, Alvarez ML, Makowska JS, Marinho S, Mendoza-Hernández DA, Pagani M, Pino VP, Parisi CAS, Park HS, Peter J, Phillips EJ, Risma K, Solano-Solares E, Tanno LK, Valluzzi RL, Vazquez-Revuelta P, Watts TJ, Yamaguchi M.
World Allergy Organ J. 2025 Sep.18(9):101087.
PMID: 40933958
FI: 4,3
http://dx.doi.org/10.1016/j.waojou.2025.101087
Addressing the Growing Role of Junior Members in EAACI.
Alves PB, Pablo-Torres C, Karavelia A, Fernandez-Santamaria R, Giovannini M, Vecillas LL, Shamji M, Torres MJ.
Allergy. 2025 Sep.80(9):2682-2685.
PMID: 40726202
FI: 12
http://dx.doi.org/10.1111/all.16681
A Novel Questionnaire and Algorithm for Work-Related Asthma Screening and Surveillance: An EAACI Task Force Report.
Jeebhay MF, Suojalehto H, Tarlo SM, Suarthana E, Cullinan P, Lindström I, Mason P, Munoz X, Raulf M, Valverde M, Walusiak-Skorupa J, Henneberger P.
Allergy. 2025 Jul 19.
PMID: 40682334
FI: 12
http://dx.doi.org/10.1111/all.16647
Roadblocks of Urinary EV Biomarkers: Moving Toward the Clinic.
Droste M, Puhka M, van Royen ME, Ng MSY, Blijdorp C, Alvarez-Llamas G, Borràs FE, Büscher AK, Bussolati B, Dear JW, Falcón-Pérez JM, Giebel B, Grange C, Hoorn EJ, Leivo J, Lenassi M, Llorente A, Lucien F, Mertens I, Mischak H, Pink D, Tertel T, Tiwari S, Di Vizio D, Yuen PST, Zarovni N, Jenster G, Burger D, Martens-Uzunova ES, Erdbrügger U.
J Extracell Vesicles. 2025 Jul.14(7):e70120.
PMID: 40673839
FI: 14,5
http://dx.doi.org/10.1002/jev2.70120
FEV1Q as a Predictive Metric for Asthma Outcomes.
Betancor D, Olaguibel JM, Del Pozo V, Alvarez Puebla MJ, Arismendi E, Barroso B, Bobolea I, Cárdaba B, Cañas JA, Domínguez-Ortega J, Cruz MJ, Curto E, Garcia de la Fuente A, González-Barcala FJ, Luna-Porta JA, Martínez-Rivera C, Mullol J, Muñoz X, Picado C, Plaza V, Quirce S, Rial MJ, Soto-Retes L, Valverde-Monge M, Mahíllo-Fernández I, Sastre J.
Arch Bronconeumol. 2025 Jul.61(7):434-437.
PMID: 40087119
FI: 9,2
http://dx.doi.org/10.1016/j.arbres.2025.02.011
Molecular Study from the Signaling Pathways of Four Potential asthma triggers: AKT1, MAPK13, STAT1, and TLR4.
Cremades-Jimeno L, López-Ramos M, Fernández-Santamaría R, De Pedro MÁ, Mahillo I, Rosales-Ariza C, Olaguibel JM, Pozo VD, Caballero ML, Luna-Porta JA, Quirce S, Barroso B, Betancor D, Valverde-Monge M, Sastre J, Baos S, Cárdaba B.
Int J Mol Sci. 2025 Jun 28.26(13).
PMID: 40650018
FI: 4,9
http://dx.doi.org/10.3390/ijms26136240
Perspectives in the Molecular Mechanisms Underlying Anaphylaxis.
Esteban V, Skrabski F, Perales-Chorda C, Puente-Crespo Y, Muñoz-Cano R, Cardona V, Anaphylaxis Committee of the Spanish Society of Allergy and Immunology (SEAIC).
J Investig Allergol Clin Immunol. 2025 Jun 27:0.
PMID: 40576298
FI: 6,7
http://dx.doi.org/10.18176/jiaci.1080
Isolated positivity for anti-ribosomal P antibodies and its utility in clinical practice: a literature review and description of 16 cases.
Blázquez-Sánchez T, Just-Balerdi MB, Guzmán-López K, Torres-Roselló A, Heras-Recuero E, García-Fernández A, Rengifo-García F, Caraballo-Salazar C, Martínez-Becerra MJ, Vegas-Sánchez MC, González-Gay MÁ.
Clin Exp Rheumatol. 2025 Jun 03.
PMID: 40470555
FI: 3,3
http://dx.doi.org/10.55563/clinexprheumatol/b5v910
Flow Cytometry Analysis of Mesenchymal Stem Cells: A Predictive Biomarker for Leukemia Transformation in Myelodysplastic Syndrome.
Atance M, Serrano C, Soto C, Alonso-Domínguez JM, Blas C, Mata R, Castaño T, Perlado S, Arquero T, López-Lorenzo JL, Pérez MÁ, Rosado B, Martos R, Rio-Machin A, Llamas-Sillero P, Salgado RN, Serrano-López J.
EJHaem. 2025 Jun.6(3):e70059.
PMID: 40438705
FI: 1,2
http://dx.doi.org/10.1002/jha2.70059
Phenotypic Characteristics of Occupational Asthma Caused by Persulfate Salts in Hairdressers: A Multicenter Cohort Study.
Doyen V, Thirionet R, Migueres N, Vandenplas O, Sastre J, Valverde-Monge M, Grydeland TB, Munoz X, Romero-Mesones C, Suojalehto H, Suuronen K, van Kampen V, Eisenhawer C, Folletti I, Jacobsen IB, Walusiak-Skorupa J, Mason P, Preiser AM, Quirce S, Walters G, Rifflart C, de Blay F, Svanes C, European network for the PHenotyping of OCcupational ASthma (E-PHOCAS).
J Allergy Clin Immunol Pract. 2025 Jun.13(6):1397-1404.e5.
PMID: 40120807
FI: 6,6
http://dx.doi.org/10.1016/j.jaip.2025.03.015
Revisiting the Impact of Misdiagnosed Drug Hypersensitivity in Hospitalized Patients: A 10-Year Perspective.
Bernaola J, Otal-Buesa M, Barroso B, Valverde-Monge M, Sastre J.
J Investig Allergol Clin Immunol. 2025 Jun 02.35(3):223-224.
PMID: 40029192
FI: 6,7
http://dx.doi.org/10.18176/jiaci.1056
Endotypes in Immune Mediated Drug Reactions: Present and Future of Relevant Biomarkers. An EAACI Task Force Report.
Mayorga C, Fernandez-Santamaria R, Çelik GE, Labella M, Murdaca G, Sokolowska M, Naisbitt D, Sabato V.
Allergy. 2025 May 07.
PMID: 40329700
FI: 12
http://dx.doi.org/10.1111/all.16576
CAR-T Cell Therapy in Autoimmune Setting: A New Appealing Approach Extendable to Allergy?
Rossi F, Fernandez Santamaria R, Castagnoli R.
Allergy. 2025 May 06.
PMID: 40326855
FI: 12
http://dx.doi.org/10.1111/all.16585
Predatory mite Cheyletus eruditus as a novel allergenic source: Identification of its allergens and cross-reactivity.
Castromil-Benito ES, Betancor D, Parrón-Ballesteros J, Gutiérrez-Díaz G, González-Pérez R, Poza-Guedes P, Bernaola J, Mederos-Luis E, Rial Prado MJ, Iraola V, Morales MM, Cuesta-Herranz J, Villalba M, Pastor-Vargas C.
J Allergy Clin Immunol Pract. 2025 Apr 29.
PMID: 40312008
FI: 6,6
http://dx.doi.org/10.1016/j.jaip.2025.04.034
Pulse-Generator Rejection of Probable Allergic Origin in Deep Brain Stimulation: A Rare Complication Successfully Managed with a Polytetrafluoroethylene-Covered Device.
Ayerbe J, Barroso B, García-Ruiz PJ, Pastor-Nieto MA, Sastre J, Cabrera-Montes J.
Mov Disord Clin Pract. 2025 Apr 18.
PMID: 40248978
FI: 2,7
http://dx.doi.org/10.1002/mdc3.70086
Genome-wide Association Study of Asthma Exacerbations in the Spanish Population.
Martin-Gonzalez E, Perez-Garcia J, Martin-Almeida M, Hernández-Pérez JM, González-Pérez R, Sardón O, Pérez-Pérez JA, González-Carracedo MA, Poza-Guedes P, Sánchez-Machín I, Mederos-Luis E, Corcuera P, López-Fernández L, Román-Bernal B, González-García LM, Cruz MJ, González-Barcala FJ, Martínez-Rivera C, Mullol J, Muñoz X, Olaguibel JM, Plaza V, Quirce S, Valero A, Sastre J, Del Pozo V, Villar J, Lorenzo-Diaz F, Pino-Yanes M.
Arch Bronconeumol. 2025 Mar 20.
PMID: 40187921
FI: 9,2
http://dx.doi.org/10.1016/j.arbres.2025.03.012
Comparison of the EPOS 2020 and POLINA 2.0 guidelines for indicating biologic treatment in adults with chronic rhinosinusitis and nasal polyps.
Golet M, Padullés-Zamora N, Portillo A, Caballero JM, Esquerre MM, Sastre J, Alobid I, González-Compta X.
Acta Otorrinolaringol Esp (Engl Ed). 2025 Mar 21:512224.
PMID: 40122169
FI: 1,1
http://dx.doi.org/10.1016/j.otoeng.2025.512224
Climate Change-Associated Environmental Factors and Pollutants: Impact on Allergic Diseases, Epidemiology, Severity, and Health Care Burden.
Montoro J, Antolín-Amérigo D, Izquierdo-Domínguez A, Zapata JJ, García-Gallardo MV, González R, Armentia A, Rondón C, Fernández MM, Pedrero SG, Valero A.
J Investig Allergol Clin Immunol. 2025 Mar 13:0.
PMID: 40079945
FI: 6,7
http://dx.doi.org/10.18176/jiaci.1067
The Role of IgE in Crohn's Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3+ Tregs.
de la Rocha-Muñoz A, Benito-Villalvilla C, Olivares D, Sirvent S, García-Brenes MA, Angelina A, Martín-Cruz L, Cuesta J, Tassinari P, Jaumont X, Taxonera C, Palomares O.
Allergy. 2025 Mar 07.
PMID: 40052502
FI: 12
http://dx.doi.org/10.1111/all.16517
EAACI Guidelines on Environmental Science for Allergy and Asthma-Recommendations on the Impact of Indoor Air Pollutants on the Risk of New-Onset Asthma and on Asthma-Related Outcomes.
Agache I, Annesi-Maesano I, Cecchi L, Biagioni B, Chung F, D'Amato G, Damialis A, Del Giacco S, Dominguez Ortega J, Galán C, Gilles S, Holgate S, Jeebhay M, Kazadzis S, Nadeau K, Papadopoulos NG, Quirce S, Sastre J, Traidl-Hoffmann C, Walusiak-Skorupa J, Zemelka-Wiacek M, Jutel M, Akdis CA.
Allergy. 2025 Mar.80(3):651-676.
PMID: 40018799
FI: 12
http://dx.doi.org/10.1111/all.16502
Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK-air Study.
Sousa-Pinto B, Costa EM, Vieira RJ, Klimek L, Czarlewski W, Pfaar O, Bedbrook A, Amaral R, Brussino L, Kvedariene V, Larenas-Linnemann DE, Iinuma T, Pham-Thi N, Regateiro FS, Taborda-Barata L, Ventura MT, Ansotegui IJ, Bergmann KC, Canonica GW, Cardona V, Cecchi L, Cherrez-Ojeda I, Cingi C, Cruz AA, Del Giacco S, Devillier P, Fokkens WJ, Gemicioglu B, Haahtela T, Ivancevich JC, Kuna P, Kraxner H, Laune D, Louis R, Makris M, Morais-Almeida M, Mösges R, Niedoszytko M, Papadopoulos NG, Patella V, Pereira AM, Reitsma S, Robles-Velasco K, Rouadi PW, Samolinski B, Sova M, Toppila-Salmi SK, Sastre J, Valiulis A, Yorgancioglu A, Zidarn M, Zuberbier T, Fonseca JA, Bousquet J, MASK‐air think tank.
Clin Exp Allergy. 2025 Mar.55(3):226-238.
PMID: 39956639
FI: 6,4
http://dx.doi.org/10.1111/cea.70004
Prevalence and Mite Allergen Recognition in an Area of Low Environmental Exposure.
Betancor D, Castromil-Benito ES, Bernaola J, Parrón-Ballesteros J, Pastor-Vargas C, Cuesta-Herranz J.
Clin Exp Allergy. 2025 Mar.55(3):267-269.
PMID: 39915232
FI: 6,4
http://dx.doi.org/10.1111/cea.70006
Basophil Activation Test: An Additional Diagnostic Tool in Vitamin B12 Allergy.
Morales-Hidalgo A, Pérez-Montoya M, Cañas JA, Valverde-Monge M, Rodrigo-Muñoz JM, Gil-Martínez M, Gómez-López A, Otal-Buesa M, Del Pozo Abejón V, Fernández-Nieto M.
J Investig Allergol Clin Immunol. 2025 Feb 25:0.
PMID: 39998864
FI: 6,7
http://dx.doi.org/10.18176/jiaci.1048
Generalized Eczema as a Transient Paradoxical Adverse Effect of Dupilumab.
Betancor D, Valverde-Monge M, Díaz-Recuero JL, Jo-Velasco ME, Del Pozo V, Sastre J.
J Investig Allergol Clin Immunol. 2025 Feb 20:0.
PMID: 39977014
FI: 6,7
http://dx.doi.org/10.18176/jiaci.1051
EAACI Clinical and Research Fellowship Program: Shaping the Future of Allergy and Clinical Immunology.
Fernandez Santamaria R, Karavelia A, Giovannini M, De Las Vecillas L, Bonadonna P, Del Giacco S, Pfaar O, Walusiak Skorupa J, Moreira A, Torres MJ, Shamji M, Palomares O.
Allergy. 2025 Jan 27.
PMID: 39868865
FI: 12
http://dx.doi.org/10.1111/all.16484
Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users.
Sousa-Pinto B, Savouré M, Vieira RJ, Amaral R, Czarlewski W, Bedbrook A, Valiulis A, Kvedariene V, Brussino L, Gemicioglu B, Haahtela T, Klimek L, Kraxner H, Larenas-Linnemann DE, Pfaar O, Regateiro FS, Samolinski B, Taborda-Barata L, Toppila-Salmi S, Ventura MT, Ansotegui IJ, Braido F, Canonica GW, Cecchi L, Cruz AA, Devillier P, Fokkens WJ, Gil-Mata S, Giuliano AF, Ivancevich JC, Kuna P, Kupczyk M, Louis G, Louis R, Makris M, Morais-Almeida M, Mullol J, Nadif R, Niedoszytko M, Okamoto Y, Ollert M, Papadopoulos NG, Patella V, Pawankar R, Pereira AM, Pétré B, Pham-Thi N, Roche N, Rouadi PW, Sastre J, Scichilone N, Sheikh A, Sova M, Todo-Bom A, Yorgancioglu A, Zidarn M, Anto JM, Zuberbier T, Fonseca JA, Bousquet J.
J Investig Allergol Clin Immunol. 2025 Jan 23:0.
PMID: 39846812
FI: 6,7
http://dx.doi.org/10.18176/jiaci.1047
Anaphylaxis: Spotlight on Inflammation.
Nuñez-Borque E, Dribin TE, Rodriguez Del Rio P, Camargo CA, Esteban V, du Toit G, Jiménez-Saiz R, Giovannini M.
Clin Exp Allergy. 2025 Jan.55(1):8-10.
PMID: 39777926
FI: 6,4
Projects, Contracts and Observational Studies
PUBLIC
Sources of public funding for projects being developed at the IIS-FJD:

|
REFERENCE |
PROJECT TITLE |
PRINCIPAL RESEARCHER |
TYPE OF PROJECT |
TOTAL FUNDING |
|
CA21147 |
EUROPEAN NETWORK ON OPTIMISING TREATMENT WITH THERAPEUTIC ANTIBODIES IN CHRONIC INFLAMMATORY DISEASES (ENOTTA) |
MARTINEZ BECERRA, MARIA JOSE |
INTERNATIONAL COLLABORATION NETWORKS |
€0,00 |
|
CB06/06/0013 |
GRUPO DE INVESTIGACION DEL CIBER DE ENFERMEDADES RESPIRATORIAS (CIBERES) |
DEL POZO ABEJON, MARIA VICTORIA |
CIBER |
€0,00 |
|
PI23/00524 |
DESCIFRANDO NUEVAS VÍAS TERAPÉUTICAS Y BIOMARCADORES DIAGNÓSTICOS Y DE SEGUIMIENTO PARA EL MANEJO DEL ASMA: MÁS ALLÁ DE LA INFLAMACIÓN DE TIPO 2 |
CARDABA OLOMBRADA, BLANCA |
CLINICAL RESEARCH PROJECTS. ISCIII |
€177,500.00 |
|
PI21/00896 |
¿EXISTEN DIFERENTES SUBTIPOS DE EOSINOFILOS? RELEVANCIA CLÍNICA EN LA ERA DE LOS NUEVOS TRATAMIENTOS CON BIOLÓGICOS PARA EL ASMA GRAVE EOSINOFILICA |
DEL POZO ABEJON, MARIA VICTORIA |
CLINICAL RESEARCH PROJECTS. ISCIII |
€256,520.00 |
|
PI24/00024 |
TRIUMFAS: TRATAMIENTO PERSONALIZADO EN LA ASMA GRAVE EOSINOFÍLICA CON BIOLÓGICOS: ¿PUEDE MODIFICAR EL CURSO DE LA ENFERMEDAD? |
DEL POZO ABEJON, MARIA VICTORIA |
CLINICAL RESEARCH PROJECTS. ISCIII |
€202,500.00 |
|
PI21/00158 |
ESTUDIO TRANSLACIONAL EN ANAFILAXIA: BÚSQUEDA DE BIOMARCADORES E INVESTIGACIÓN DE SU ETIOPATOGÉNESIS PARA UNA APROXIMACIÓN CLÍNICA PERSONALIZADA Y PRECISA. |
ESTEBAN VAZQUEZ, VANESA |
CLINICAL RESEARCH PROJECTS. ISCIII |
€165,770.00 |
|
PI24/00360 |
DIAGNÓSTICO DIFERENCIAL DE REACCIONES ALÉRGICAS Y ANAFILAXIA. IMPLICACIONES TERAPÉUTICAS DE LOS MICROAMBIENTES RELACIONADOS CON LAS VESÍCULAS EXTRACELULARES Y EL GLICOCÁLIX ENDOTELIAL. |
ESTEBAN VAZQUEZ, VANESA |
CLINICAL RESEARCH PROJECTS. ISCIII |
€227,500.00 |
|
PI23/00100 |
ANEURISMA AÓRTICO TORÁCICO IDIOPÁTICO: DE LA INTERACCIÓN CELULAR A LA MEDICINA PERSONALIZADA |
MARTIN LORENZO, MARTA |
CLINICAL RESEARCH PROJECTS. ISCIII |
€140,000.00 |
|
PID2023-149828OB-I00 |
NUEVAS HERRAMIENTAS NO INVASIVAS DE EVALUACIÓN DEL RIÑÓN DONADO QUE ASISTAN EN LA TOMA DE DECISIONES PARA AUMENTAR LA TASA DE DONACIÓN RENAL (OPTIREN) |
ALVAREZ LLAMAS, GLORIA |
CLINICAL RESEARCH PROJECTS. MINISTRY |
€150,000.00 |
|
CPP2024-011392 |
DESARROLLO DE ORK-2 UN FÁRMACO POTENTE Y SELECTIVO "FIRST-IN-CLASS" PARA EL TRATAMIENTO DEL ASMA GRAVE |
DEL POZO ABEJON, MARIA VICTORIA |
EXPERIMENTAL RESEARCH PROJECTS. MINISTRY |
€347,770.75 |
|
FI21/00128 |
CONTRATO PFIS: ARIADNA MARTÍN BLÁZQUEZ |
ALVAREZ LLAMAS, GLORIA |
PREDOCTORAL RESEARCH. ISCIII |
€119,567.00 |
|
CP23/00017 |
EXOSOMAS Y MICROARN: NUEVAS HERRAMIENTAS TERAÉUTICAS Y DIAGNÓSTICAS EN LA INTERACCIÓN ENTRE ASMA Y ALERGIA ALIMENTARIA - CONTRATO MIGUEL SERVET: JOSE ANTONIO CAÑAS MAÑAS |
CAÑAS MAÑAS, JOSE ANTONIO |
POSTDOCTORAL RESEARCH. ISCIII |
€308,600.00 |
|
CD23/00118 |
CONTRATO SARA BORRELL: RUBÉN FERNÁNDEZ SANTAMARÍA |
CARDABA OLOMBRADA, BLANCA |
POSTDOCTORAL RESEARCH. ISCIII |
€95,000.00 |
|
FI24/00194 |
CONTRATO PFIS: CRISTINA ROSALES ARIZA |
CARDABA OLOMBRADA, BLANCA |
PREDOCTORAL RESEARCH. ISCIII |
€89,900.00 |
|
CD22/00073 |
CONTRATO SARA BORRELL: ÓSCAR LÓPEZ PÉREZ |
ESTEBAN VAZQUEZ, VANESA |
POSTDOCTORAL RESEARCH. ISCIII |
€95,000.00 |
|
FI22/00046 |
CONTRATO PFIS: SERGIO FERNÁNDEZ BRAVO |
ESTEBAN VAZQUEZ, VANESA |
PREDOCTORAL RESEARCH. ISCIII |
€119,567.00 |
|
CP22/00100 |
ANEURISMA DE AORTA TORÁCICA: DE LOS MECANISMOS AÓRTICOS IN SITU A LOS MARCADORES PLASMÁTICOS DE DIAGNÓSTICO. CONTRATO MIGUEL SERVET: MARTA MARTÍN LORENZO |
MARTIN LORENZO, MARTA |
POSTDOCTORAL RESEARCH. ISCIII |
€308,600.00 |
|
PIPF-2022/SAL-GL-25760 |
CONTRATO PIPF: ROCÍO RUÍZ JIMÉNEZ |
ALVAREZ LLAMAS, GLORIA |
PREDOCTORAL RESEARCH. CAM |
€116,630.38 |
|
PIPF-2022/SAL-GL-24982 |
CONTRATO PIPF: LUCÍA PALACIO GARCÍA |
ESTEBAN VAZQUEZ, VANESA |
PREDOCTORAL RESEARCH. CAM |
€116,630.38 |
|
PEJ-2023-AI/SAL-GL-27883 |
CONTRATO AYUDANTE DE INVESTIGACIÓN CAM: MARÍA DE SANCHA MALUENDA (ANT. ALFREDO RUS SÁNCHEZ) |
MARTIN LORENZO, MARTA |
PREDOCTORAL RESEARCH. CAM |
€47,964.58 |
PRIVATE
|
REFERENCE |
PROJECT TITLE |
PRINCIPAL RESEARCHER |
TYPE OF PROJECT |
|
3371/007 |
MARCADORES BIOLÓGICOS PREDICTORES DE LA FUNCIONALIDAD RENAL POST-TRASPLANTE A LARGO PLAZO: APROXIMACIÓN MULTI-ÓMICA EN BIOPSIA LÍQUIDA DE DONANTE |
ALVAREZ LLAMAS, GLORIA |
RESEARCH PROJECTS. COMPETITIVE |
|
181750/001 |
DIAMOMS: MEJORA DIAGNÓSTICA DEL ASMA Y MONITORIZACIÓN DEL TRATAMIENTO CON FÁRMACOS BIOLÓGICOS A TRAVÉS DEL METABOLOMA, SECRETOMA Y MIRNAOMA. |
CAÑAS MAÑAS, JOSE ANTONIO |
RESEARCH PROJECTS. COMPETITIVE |
|
181750/002 |
EPIALER: SEÑALES EPIGENÉTICAS (METILOMA Y MICROARNS): UNA NUEVA ALTERNATIVA PARA EL ASMA Y LA ALERGIA PEDIÁTRICA |
CAÑAS MAÑAS, JOSE ANTONIO |
RESEARCH PROJECTS. COMPETITIVE |
|
25089/001 |
ASSESSMENT AND POTENTIAL IMPROVEMENT OF ADHERENCE IN ALLERGEN IMMUNOTHERAPY |
ESTEBAN GORGOJO, IGNACIO |
RESEARCH PROJECTS |
|
37285/003 |
ESTUDIO DE ACTIVACIÓN DE RUTAS MOLECULARES EN RESPUESTA A TRATAMIENTO CON EXTRACTOS METABOLAID Y NOPE |
ESTEBAN VAZQUEZ, VANESA |
RESEARCH PROJECTS |
|
4216/015 |
FOLLOW-UP OF SPANISH PROSPECTIVE ASTHMA AND NASAL POLYPOSIS REGISTRY |
SASTRE DOMINGUEZ, JOAQUIN |
RESEARCH PROJECTS |
|
EO178-20_FJD |
ESTUDIO OBSERVACIONAL PROSPECTIVO PARA EVALUAR LA SEGURIDAD Y LA EFECTIVIDAD DE LA INMUNOTERAPIA CON UN ALERGOIDE DE POLEN DE OLIVO Y GRAMÍNEAS EN PACIENTES CON ASMA ALÉRGICA ESTACIONAL |
VALVERDE MONGE, MARCELA |
OBSERVATIONAL STUDIES |
|
PIC204-22_FJD |
ESTUDIO OBSERVACIONAL PROSPECTIVO PARA EVALUAR LA EFICACIA DE LA INMUNOTERAPIA EN DISTINTAS PRESENTACIONES, POLIMERIZADO O DEPOT, FRENTE A EPITELIOS DE PERRO O GATO EN PACIENTES ALERGICOS A EPITELIOS DE ANIMALES DOMESTICOS |
BARROSO GARCIA, BLANCA |
RESEARCH PROJECTS |
|
PIC199-21_FJD |
ANÁLISIS DE CAMBIOS EPIGENÉTICOS EN ALERGIA A PROTEÍNA DE LECHE DE VACA EN LACTANTES: CAMBIOS INMUNOLÓGICOS EN LOS DIFERENTES PERFILES Y TRAS INMUNOTERAPIA ORAL |
DEL POZO ABEJON, MARIA VICTORIA |
RESEARCH PROJECTS |
|
PIC108-24_FJD |
ESTUDIO DE TIEMPOS Y MOVIMIENTOS (T&M) PARA CUANTIFICAR EL TIEMPO Y LOS RECURSOS ASOCIADOS CON EL TRATAMIENTO Y LA ADMINISTRACIÓN DE PRODUCTOS BIOLÓGICOS INYECTABLES PARA TRATAR A PACIENTES CON ASMA GRAVE (AG) O RINOSINUSITIS CRÓNICA CON PÓLIPOS NASALES (RSCCPN). |
FERNANDEZ NIETO, MAR |
RESEARCH PROJECTS |
|
00400057 |
PRÁCTICAS EXTERNAS |
CARDABA OLOMBRADA, BLANCA |
TRAINING/TEACHING |
|
00400045 |
EOS ACADEMY 2025. TALLER INMERSIVO EN EL HOSPITAL IIS-FJD |
DEL POZO ABEJON, MARIA VICTORIA |
TRAINING/TEACHING |
Clinical trials
The clinical trials listed below were in the recruitment phase in 2025. If you are interested in participating in any of the currently open trials, more information is available on the website (https://ensayos.quironsalud.es/)
|
EudraCT Number |
TITLE |
PHASE |
MC1 |
INT2 |
PRINCIPAL RESEARCHER |
|
2022-003466-20 |
ESTUDIO EN FASE I/IIA PARA EVALUAR LOS EFECTOS DE ARO-RAGE EN SUJETOS SANOS Y PACIENTES CON ENFERMEDAD INFLAMATORIA PULMONAR |
II |
YES |
YES |
JOAQUIN SASTRE DOMINGUEZ |
|
2024-518321-15-00 |
A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, DOSE FINDING, PARALLEL GROUP, PHASE 2 STUDY OF AN ANTI-TSLP ANTIBODY (GSK5784283) IN ADULTS AGED 18 TO 75 YEARS OF AGE WITH UNCONTROLLED ASTHMA |
II |
YES |
YES |
MAR FERNANDEZ NIETO |
|
2019-002865-37 |
ENSAYO CLÍNICO DE EFICACIA Y SEGURIDAD, PROSPECTIVO, MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO CONTROLADO CON PLACEBO, CON INMUNOTERAPIA SUBCUTÁNEA EN PACIENTES CON RINITIS/RINOCONJUNTIVITIS CON O SIN ASMA DE LEVE A MODERADA SENSIBILIZADOS A GRAMÍNEAS Y CUPRESÁCEAS |
III |
YES |
NO |
DIANA BETANCOR PEREZ |
|
2024-512113-41-00 |
A MULTICENTRE, RANDOMISED, OPEN-LABEL, PARALLEL-GROUP, PHASE IIIB STUDY TO ASSESS THE POTENTIAL FOR TEZEPELUMAB-TREATED PATIENTS WITH SEVERE ASTHMA TO REDUCE BACKGROUND THERAPY WHILE SUSTAINING ASTHMA CONTROL AND CLINICAL REMISSION (ARRIVAL) |
III |
YES |
YES |
DIANA BETANCOR PEREZ |
|
2019-002811-25 |
ENSAYO CLÍNICO DE EFICACIA Y SEGURIDAD, PROSPECTIVO, MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO CONTROLADO CON PLACEBO, CON INMUNOTERAPIA SUBCUTÁNEA EN PACIENTES CON RINITIS/RINOCONJUNTIVITIS CON O SIN ASMA DE LEVE A MODERADA SENSIBILIZADOS A GRAMÍNEAS Y OLIVO |
III |
YES |
NO |
FRANCISCO JAVIER RUIZ HORNILLOS |
|
2020-003612-28 |
ESTUDIO DE 52 SEMANAS DE DURACIÓN, ALEATORIZADO, DOBLE CIEGO, CON DOBLE SIMULACIÓN, DE GRUPOS PARALELOS, MULTICÉNTRICO, DE NO INFERIORIDAD, PARA EVALUAR LA TASA DE EXACERBACIÓN, LAS MEDICIONES ADICIONALES DE CONTROL DEL ASMA Y LA SEGURIDAD EN PARTICIPANTES ADULTOS Y ADOLESCENTES CON ASMA GRAVE CON FENOTIPO EOSINOFÍLICO TRATADOS CON GSK3511294 EN COMPARACIÓN CON MEPOLIZUMAB O BENRALIZUMAB |
III |
YES |
YES |
MAR FERNANDEZ NIETO |
|
2023-509001-76-00 |
A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTICENTER STUDY TO EVALUATE THE LONG-TERM SAFETY OF SALBUTAMOL RESCUE MEDICATION WHEN ADMINISTERED VIA METERED DOSE INHALERS CONTAINING THE PROPELLANT HFA-152A OR REFERENCE HFA-134A |
III |
YES |
YES |
MAR FERNANDEZ NIETO |
|
NA |
IMPACTO DEL EJERCICIO FÍSICO EN EL CONTROL Y MANEJO DEL ASMA EN ADULTOS |
NA |
NO |
NO |
SARAH MICOZZI |
|
MC1: MULTICENTRE INT2: INTERNATIONAL |
|||||
Patents (revisar)
Title: Un método pronostico y kit para la identificación de riesgo de desarrollo de albuminuria, riesgo de daño renal y riesgo cardiovascular en un sujeto humano hipertenso.
Application No: P201630559
Main entities: FUIHNP (20%), Imas12 (20%), IIS-FJD (60%)
Inventors: Gloria Alvarez Llamas, Fernando Vivanco, Laura González Calero, Mª Eugenia Gonzalez Barderas, Luis Miguel Ruilope Urioste.
Title: Biomarcadores diferenciales de asma.
Application No: P201730947
Main entities: FIIS-FJD (100%)
Inventors: Blanca Cárdaba Olombrada; Selene Baos Muñiz; David Calzada Ricote; Lucía Cremades Jimeno.
Title: In vitro methods for the diagnosis of allergic asthma or nonallergic asthma in a subject suffering from asthma, or for the prognosis of asthma.
Application No: EP24382299.6
Main entities: FIIS-FJD (90%), CIBER (10%)
Inventors: Blanca Cárdaba Olombrada, Lucía Cremades Jimeno, Selene Baos Muñiz, María López Ramos, Ignacio Mahillo Fernández, Mª Ángeles De Pedro.










